Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

231
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
231
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

320
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
320
The Evidence for Evolution02:55

The Evidence for Evolution

48.4K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.4K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

250
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
250
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

324
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
324
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

278
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of intradermal and serum testing for environmental allergen-specific immunoglobulin E determination in a laboratory colony of cats with naturally acquired atopic syndrome.

Veterinary dermatology·2024
Same author

Pathology in Practice.

Journal of the American Veterinary Medical Association·2022
Same author

Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis.

BMC veterinary research·2022
Same author

Cardiac Disease of Raptors.

Journal of avian medicine and surgery·2022
Same author

Pharmacokinetics and safety of zonisamide after oral administration of single and multiple doses to Hispaniolan Amazon parrots (Amazona ventralis).

American journal of veterinary research·2019
Same author

Identification and quantification of domestic feline cytochrome P450 transcriptome across multiple tissues.

Journal of veterinary pharmacology and therapeutics·2018

Related Experiment Video

Updated: Feb 11, 2026

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.2K

The Educated Guess: Determining Drug Doses in Exotic Animals Using Evidence-Based Medicine.

Marike Visser1, Seth C Oster2

  • 1Department of Anatomy, Physiology and Pharmacology, Auburn University, 1010 Wire Road, Auburn, AL 36849, USA.

The Veterinary Clinics of North America. Exotic Animal Practice
|April 16, 2018
PubMed
Summary

Selecting appropriate drug doses across species is challenging due to limited pharmacokinetic data. This study explores methods for veterinary dose extrapolation, considering species-specific metabolism and physiology.

Keywords:
Allometric scalingDosing selectionEvidence-based veterinary medicinePharmacokinetics

More Related Videos

Author Spotlight: Establishing a Rodent Model for Investigating Depression Factors in Traditional Mongolian Medicine
05:56

Author Spotlight: Establishing a Rodent Model for Investigating Depression Factors in Traditional Mongolian Medicine

Published on: October 27, 2023

1.8K
An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules
05:59

An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules

Published on: November 4, 2022

2.2K

Related Experiment Videos

Last Updated: Feb 11, 2026

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.2K
Author Spotlight: Establishing a Rodent Model for Investigating Depression Factors in Traditional Mongolian Medicine
05:56

Author Spotlight: Establishing a Rodent Model for Investigating Depression Factors in Traditional Mongolian Medicine

Published on: October 27, 2023

1.8K
An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules
05:59

An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules

Published on: November 4, 2022

2.2K

Area of Science:

  • Veterinary pharmacology
  • Comparative medicine
  • Drug development

Background:

  • Species-specific pharmacokinetic and pharmacodynamic data are crucial for accurate pharmaceutical dose selection.
  • Current dose extrapolation methods like linear and allometric scaling have limitations, potentially leading to toxicity or failing for certain species or drug types.

Purpose of the Study:

  • To review and discuss methods for veterinary dose design when specific pharmacokinetic data is unavailable.
  • To highlight the importance of considering species similarity and physiological differences for evidence-based dose selection.

Main Methods:

  • Review of existing dose extrapolation techniques, including linear and allometric scaling.
  • Discussion of limitations associated with current methods, such as ignoring species drug metabolism and hepatic pathways.
  • Consideration of evidence-based veterinary medicine principles for dose design.

Main Results:

  • Linear scaling based on weight does not account for species-specific drug metabolism, increasing toxicity risk.
  • Allometric scaling, while correlating body weight and metabolic rate, is unsuitable for drugs with significant hepatic metabolism and cannot be applied to avians or reptiles.
  • Physiological differences between animal classes must be considered for effective dose extrapolation.

Conclusions:

  • Accurate veterinary drug dosing requires species-specific data, and current extrapolation methods are often inadequate.
  • A move towards evidence-based veterinary medicine, considering species physiology and metabolic pathways, is essential for safer and more effective drug use.
  • Further research into advanced dose extrapolation models tailored for veterinary species is warranted.